Metraipolis › archive › dc_fa7c826d25da

Assessing Treatment Efficacy for Dermatologic Immune-Related Adverse Events: A Systematic Review — Europe PMC PMID:41069636

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41069636
DOI
10.1016/j.xjidi.2025.100410
License (as archived)
solo-consultazione
Archived
2026-11-10T04:06:53.686Z
SHA-256 of the archived text
59c647fe55e41c9c1fe8ec63134bee42d5c4349aa6788c1da3604f40a479306f
Stable URL of this page
https://metraipolis.com/documento/dc_fa7c826d25da

How to cite

Assessing Treatment Efficacy for Dermatologic Immune-Related Adverse Events: A Systematic Review — Europe PMC PMID:41069636 — Europe PMC (en), https://europepmc.org/article/MED/41069636 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fa7c826d25da (Metraipolis archive dc_fa7c826d25da, sha256 59c647fe55e41c9c1fe8ec63134bee42d5c4349aa6788c1da3604f40a479306f)
BibTeX
@misc{dcfa7c826d25da,
  title = {Assessing Treatment Efficacy for Dermatologic Immune-Related Adverse Events: A Systematic Review — Europe PMC PMID:41069636},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41069636},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fa7c826d25da; sha256 59c647fe55e41c9c1fe8ec63134bee42d5c4349aa6788c1da3604f40a479306f},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41069636. Agents can read the archived copy with the MCP tool read_document.